---
title: "Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294684860.md"
description: "A Phase 2 clinical trial proposal has been submitted, outlining plans for a small-scale study aimed at facilitating regulatory discussions and potential approval in the event of favorable outcomes. The study is intended to involve a limited number of participants and is crucial for advancing the research in question."
datetime: "2026-08-03T11:03:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294684860.md)
  - [en](https://longbridge.com/en/news/294684860.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294684860.md)
generator: "portal-rs"
---

# Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome

A Phase 2 clinical trial proposal has been submitted, outlining plans for a small-scale study aimed at facilitating regulatory discussions and potential approval in the event of favorable outcomes. The study is intended to involve a limited number of participants and is crucial for advancing the research in question.

### Related Stocks

- [CANF.US](https://longbridge.com/en/quote/CANF.US.md)

## Related News & Research

- [Can-Fite BioPharma Cuts Warrant Exercise Price to Secure $4 Million Inducement Financing](https://longbridge.com/en/news/297945371.md)
- [Can-Fite reports longer-than-expected survival in Phase III Namodenoson liver cancer trial](https://longbridge.com/en/news/297773746.md)
- [Helix Launches Whole Exome+® Sequencing for Patients with Rare and Unexplained Genetic Conditions](https://longbridge.com/en/news/298630239.md)
- [Pi Network price prediction 2026–2032: Will PI recover further?](https://longbridge.com/en/news/298838405.md)
- [Decoding PI crypto’s 5% weekly rally and what developer updates mean next](https://longbridge.com/en/news/298430426.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**